HealthCor Management as of Dec. 31, 2021
Portfolio Holdings for HealthCor Management
HealthCor Management holds 67 positions in its portfolio as reported in the December 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Medtronic SHS Call Option (MDT) | 10.2 | $187M | 1.8M | 103.45 | |
Bristol Myers Squibb (BMY) | 6.1 | $113M | 1.8M | 62.35 | |
Biogen Idec (BIIB) | 5.9 | $109M | 453k | 239.92 | |
Horizon Therapeutics Pub L SHS | 4.9 | $90M | 832k | 107.76 | |
Envista Hldgs Corp (NVST) | 4.0 | $74M | 1.6M | 45.06 | |
Natera (NTRA) | 3.8 | $70M | 753k | 93.39 | |
AmerisourceBergen (COR) | 3.8 | $69M | 521k | 132.89 | |
Tenet Healthcare Corp Com New (THC) | 3.5 | $64M | 782k | 81.69 | |
Centene Corporation (CNC) | 3.4 | $62M | 750k | 82.40 | |
Pet Acquisition LLC -Class A (WOOF) | 2.9 | $54M | 2.7M | 19.79 | |
Boston Scientific Corporation (BSX) | 2.9 | $54M | 1.3M | 42.48 | |
Danaher Corporation (DHR) | 2.7 | $50M | 151k | 329.01 | |
Johnson & Johnson (JNJ) | 2.6 | $48M | 280k | 171.07 | |
Anthem (ELV) | 2.6 | $47M | 102k | 463.54 | |
Jazz Pharmaceuticals Shs Usd (JAZZ) | 2.4 | $45M | 349k | 127.40 | |
Stryker Corporation (SYK) | 2.3 | $43M | 159k | 267.42 | |
Livanova SHS (LIVN) | 2.0 | $38M | 431k | 87.43 | |
Universal Hlth Svcs CL B (UHS) | 2.0 | $37M | 286k | 129.66 | |
Select Sector Spdr Tr Sbi Healthcare (XLV) | 1.9 | $36M | 254k | 140.89 | |
Cooper Cos Com New | 1.8 | $34M | 80k | 418.94 | |
Nevro (NVRO) | 1.8 | $33M | 409k | 81.07 | |
BioCryst Pharmaceuticals (BCRX) | 1.8 | $33M | 2.4M | 13.85 | |
Neurocrine Biosciences (NBIX) | 1.7 | $31M | 366k | 85.17 | |
Abbott Laboratories (ABT) | 1.6 | $29M | 203k | 140.74 | |
Humana (HUM) | 1.4 | $25M | 55k | 463.85 | |
Syndax Pharmaceuticals (SNDX) | 1.4 | $25M | 1.2M | 21.89 | |
Revance Therapeutics (RVNC) | 1.3 | $24M | 1.4M | 16.32 | |
Hca Holdings (HCA) | 1.2 | $22M | 84k | 256.92 | |
Longview Acquisition Corp Ii Com Cl A | 1.1 | $21M | 2.1M | 9.84 | |
Pfizer (PFE) | 1.1 | $20M | 339k | 59.05 | |
Avantor (AVTR) | 1.0 | $18M | 428k | 42.14 | |
Regeneron Pharmaceuticals (REGN) | 1.0 | $18M | 28k | 631.53 | |
Abbvie (ABBV) | 0.9 | $17M | 125k | 135.40 | |
McKesson Corporation (MCK) | 0.9 | $16M | 64k | 248.57 | |
UnitedHealth (UNH) | 0.8 | $15M | 29k | 502.14 | |
Cano Health Com Cl A | 0.8 | $14M | 1.6M | 8.91 | |
BioMarin Pharmaceutical (BMRN) | 0.8 | $14M | 159k | 88.35 | |
Amgen (AMGN) | 0.8 | $14M | 63k | 224.96 | |
Research Alliance Corp Ii Com Cl A | 0.7 | $13M | 1.3M | 9.72 | |
Henry Schein (HSIC) | 0.5 | $9.9M | 128k | 77.53 | |
ImmunoGen | 0.5 | $9.7M | 1.3M | 7.42 | |
Affimed Therapeutics B V | 0.5 | $9.5M | 1.7M | 5.52 | |
Chemocentryx | 0.5 | $8.8M | 241k | 36.41 | |
Incyte Corporation (INCY) | 0.4 | $7.9M | 108k | 73.40 | |
Rapt Therapeutics (RAPT) | 0.4 | $6.7M | 181k | 36.73 | |
Quanterix Ord (QTRX) | 0.3 | $5.7M | 134k | 42.40 | |
Seagen | 0.3 | $5.2M | 34k | 154.59 | |
Hyperfine Com Cl A (HYPR) | 0.3 | $5.0M | 692k | 7.25 | |
Veracyte (VCYT) | 0.3 | $4.9M | 120k | 41.20 | |
Arya Sciences Acquisitn Corp Class A Ord Shs | 0.3 | $4.9M | 500k | 9.70 | |
Cytokinetics Com New (CYTK) | 0.2 | $4.3M | 94k | 45.58 | |
Halozyme Therapeutics (HALO) | 0.2 | $4.2M | 105k | 40.21 | |
Stereotaxis Com New (STXS) | 0.2 | $4.1M | 657k | 6.20 | |
Inspire Med Sys (INSP) | 0.2 | $4.0M | 18k | 230.07 | |
Ikena Oncology (IKNA) | 0.2 | $3.6M | 288k | 12.54 | |
Merus N V (MRUS) | 0.2 | $3.6M | 112k | 31.80 | |
Leap Therapeutics | 0.2 | $3.5M | 1.1M | 3.24 | |
Axonics Modulation Technolog (AXNX) | 0.2 | $3.3M | 59k | 56.01 | |
Pyxis Oncology Common Stock (PYXS) | 0.1 | $2.7M | 245k | 10.97 | |
Orion Acquisition Corp Com Cl A | 0.1 | $2.0M | 200k | 9.78 | |
Dice Therapeutics | 0.1 | $1.9M | 75k | 25.32 | |
Longview Acquisition Corp Ii *w Exp 99/99/999 | 0.0 | $363k | 427k | 0.85 | |
Bridgebio Pharma Call Option (BBIO) | 0.0 | $167k | 10k | 16.70 | |
Eqrx *w Exp 12/17/202 | 0.0 | $107k | 100k | 1.07 | |
Orion Acquisition Corp *w Exp 02/19/202 | 0.0 | $89k | 137k | 0.65 | |
Medicus Sciences Acquisition *w Exp 02/12/202 | 0.0 | $60k | 83k | 0.73 | |
Eucrates Biomedical Acqu Cor *w Exp 10/23/202 | 0.0 | $45k | 78k | 0.58 |